OssDsign AB (publ) (STO:OSSD)
Sweden · Delayed Price · Currency is SEK 4.075
+0.250 (6.54%)
Apr 14, 2026, 5:29 PM CET
OssDsign AB Company Description
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally.
The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects.
It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue.
The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.
OssDsign AB (publ)
| Country | Sweden |
| Founded | 2011 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 34 |
| CEO | Mark Waugh |
Contact Details
Address: Ulls väg 29C Uppsala Sweden | |
| Phone | 46 1 84 30 81 10 |
Stock Details
| Ticker Symbol | OSSD |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0012570448 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Mark Waugh B.S., M.B.A. | Chief Executive Officer |
| Anders Svensson | Chief Financial Officer |
| Dr. Tom Buckland Ph.D. | Chief Technical Officer |
| Stephen Anderson | Vice President of Marketing |
| Melanie Marshall | Vice President of Clinical and Medical Affairs |
| Eric Patermo | Vice President of Sales US |